EPS (Diluted) for AstraZeneca (AZN)
According to AstraZeneca's latest reported financial statements, the company's current diluted EPS (TTM) is $13.08. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
AZN
Currently viewingEPS (Diluted)Switch metric
TTM (last 4 quarters)
$13.08
YoY change
+190.7%
5Y CAGR
+21.8%
Peak year (2004)
$436.00
Latest annual
$13.08
EPS (Diluted) history chart for AstraZeneca (AZN) from 1990 to 2025
EPS (Diluted) history table for AstraZeneca (AZN) from 1990 to 2025
| Fiscal year | Period ended | Reported | EPS (Diluted) | YoY |
|---|---|---|---|---|
| 2025 | $13.08 | +190.7% | ||
| 2024 | $4.50 | -40.9% | ||
| 2023 | $7.62 | +80.6% | ||
| 2022 | $4.22 | +2537.5% | ||
| 2021 | $0.16 | -96.7% | ||
| 2020 | $4.88 | +136.9% | ||
| 2019 | $2.06 | -39.4% | ||
| 2018 | $3.40 | -28.3% | ||
| 2017 | $4.74 | -14.1% | ||
| 2016 | $5.52 | +23.8% | ||
| 2015 | $4.46 | +127.6% | ||
| 2014 | $1.96 | -52.0% | ||
| 2013 | $4.08 | -58.6% | ||
| 2012 | $9.86 | -32.5% | ||
| 2011 | $14.60 | +31.1% | ||
| 2010 | $11.14 | +7.3% | ||
| 2009 | $10.38 | +23.6% | ||
| 2008 | $8.40 | +12.6% | ||
| 2007 | $7.46 | -3.1% | ||
| 2006 | $7.70 | +32.3% | ||
| 2005 | $5.82 | -98.7% | ||
| 2004 | $436.00 | +22.5% | ||
| 2003 | $356.00 | +10753.7% | ||
| 2002 | $3.28 | -0.6% | ||
| 2001 | $3.30 | +15.4% | ||
| 2000 | $2.86 | +123.4% | ||
| 1999 | $1.28 | -56.2% | ||
| 1998 | $2.92 | +15.0% | ||
| 1997 | $2.54 | +9.5% | ||
| 1996 | $2.32 | +110.9% | ||
| 1995 | $1.10 | -24.7% | ||
| 1994 | $1.46 | -2.7% | ||
| 1993 | $1.50 | +341.2% | ||
| 1992 | $0.34 | -81.1% | ||
| 1991 | $1.80 | +50.0% | ||
| 1990 | $1.20 | — |
EPS (Diluted) values are taken from AstraZeneca's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, AstraZeneca (AZN) diluted EPS totalled $13.08 – surged 190.7% year-over-year.
AstraZeneca diluted EPS has recorded the values shown across consecutive periods, with a +21.8% compound annual growth rate over 2020–2025 (5 years).
AstraZeneca diluted EPS plunged from $436.00 in 2004 to $13.08 in 2025, a 97.0% drawdown.
The dataset's maximum diluted EPS sits at $436.00 (2004); the minimum reading of $0.16 dates to 2021.
AstraZeneca (AZN) sits 6th of 8 Healthcare peers we track on this metric, against a peer median of $13.73.
AstraZeneca EPS (Diluted) by Year
AstraZeneca EPS (Diluted) 2025: $13.08
AstraZeneca diluted EPS in 2025 was $13.08, surged 190.7% from 2024.
AstraZeneca EPS (Diluted) 2024: $4.50
AstraZeneca diluted EPS in 2024 was $4.50, plunged 40.9% below 2023.
AstraZeneca EPS (Diluted) 2023: $7.62
AstraZeneca diluted EPS in 2023 was $7.62, surged 80.6% from 2022.
AstraZeneca EPS (Diluted) 2022: $4.22
AstraZeneca diluted EPS in 2022 was $4.22, surged 2537.5% from 2021.
AstraZeneca EPS (Diluted) 2021: $0.16
AstraZeneca diluted EPS in 2021 was $0.16.
See more financial history for AstraZeneca (AZN).
Sector peers — EPS (Diluted)
Companies in the same sector as AstraZeneca, ranked by their latest diluted EPS.
| Company | EPS (Diluted) | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $23.03 | Healthcare |
| Eli Lilly and Company (LLY) | $22.95 | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $17.74 | Healthcare |
| Amgen Inc. (AMGN) | $14.23 | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $13.23 | Healthcare |
| Johnson & Johnson (JNJ) | $11.03 | Healthcare |
| Merck & Co., Inc. (MRK) | $7.28 | Healthcare |
| AbbVie Inc. (ABBV) | $2.37 | Healthcare |
Frequently asked questions
What is AstraZeneca's diluted EPS?
- Latest reported diluted EPS for AstraZeneca (AZN) is $13.08 (period ending December 31, 2025).
How has AstraZeneca diluted EPS changed year-over-year?
- AstraZeneca (AZN) diluted EPS changed +190.7% year-over-year on the latest annual filing.
What is the long-term growth rate of AstraZeneca diluted EPS?
- AstraZeneca (AZN) diluted EPS compound annual growth rate is +21.8% over the most recent 5 years available.
When did AstraZeneca diluted EPS hit its highest annual value?
- AstraZeneca diluted EPS reached its highest annual value of $436.00 in 2004.
What was AstraZeneca diluted EPS in 2024?
- AstraZeneca (AZN) diluted EPS in 2024 was $4.50.
What was AstraZeneca diluted EPS in 2025?
- AstraZeneca (AZN) diluted EPS in 2025 was $13.08.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
AZN Overview
Company profile, financial tools, and key metrics
AZN Revenue Counter
Earns $1,863 every second. See per minute, hour, and day.
AZN Earnings Counter
Earns $324.23 per second net profit. See per minute, hour, and day.
AZN Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
AZN What If Invested
What if you had invested $1,000? See historical returns from any date.
AZN How It Makes Money
Discover visual breakdown of $58.74B in revenue — where it comes from and where it goes.
AZN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
AZN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
AZN Daily Price Character
Steady · 49.4% historical win rate (green days). Streaks & record days.
AZN Buybacks
0.16% TTM buyback yield. Shareholder yield & SBC comparison.
AZN Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.
AZN Dividend Profile
Yield: 1.73%. Safety: 6/8. See full history.
AZN Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
AZN Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.